Back

Creative Educational Concepts, Inc.

  • Cisplatin
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Urinary Bladder Neoplasms

AI-Powered Precision Learning: Cracking the MIBC Code with Smart Navigation of (Neo)adjuvant and Perioperative Immunotherapy Options

Muscle-invasive bladder cancer (MIBC) remains one of the most aggressive urologic cancers, with poor long-term outcomes driven by limited systemic therapy options and frequent micrometastatic disease at diagnosis. Immune checkpoint inhibitors (ICIs) are transforming the treatment landscape and improving pathologic response rates and survival, but the pace of innovation has created significant challenges for clinicians to integrate into practice. At the same time, treatment-related adverse events can profoundly impact quality of life, making informed shared decision-making essential. In this CE Concepts AI-enabled clinical simulation, learners are immersed in real-world MIBC scenarios where they must evaluate evidence, navigate cisplatin eligibility and treatment selection, engage in shared decision-making with individuals facing curative-intent choice, and manage treatment/immune-related adverse events thereby building the clinical fluency required to deliver evidence-based, patient-centered care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 point

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • Board review / self-assessment
  • includes Virtual patient / simulation
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Jul 23, 2026
  • Last day to claim credit
    Jul 24, 2027 10 months left